90TEN appoints Managing Director and Director to lead award-winning PR team

Peter has been taking a leadership role at 90TEN since 2014 when he joined the consultancy as the Director of International Communications. During this time he has led the growth of the PR division and dramatically expanded its international presence and global client roster. Claire joined the 90TEN team from Ketchum as an Associate Director in 2016, and leads some of the agency’s largest accounts.

Carole North, 90TEN’s Co-Founder and Chief Executive Officer, said: “Our PR division has achieved impressive growth over the past two years, and Peter’s visionary strategic and creative direction has been instrumental in this. He has led the way in expanding our team of passionate UK and international healthcare PR experts and inspiring them to deliver work that has won our clients’ hearts as well as a host of industry awards. Both Peter and Claire share our vision for improving health and changing lives for the better, and I am delighted to see them stepping into these new roles.”

Alison Doughty takes the helm of 90TEN’s award-winning medical education team

Medical Education division. Alison’s arrival follows a year of unprecedented growth for the Battersea-based agency.

Alison was previously at Ketchum where she was Partner and Director of Ketchum Health, overseeing both the health PR team and Inspired Science, the medical education agency she founded in 2010. She started her career in medical communications in 2002 after completing a PhD at the University of Sydney and a Postdoctoral Fellowship in viral hepatitis at the University of Southern California. Alison joined Ketchum in 2008 following stints at MediTech Media and Health Interactions and a secondment to Roche in Switzerland.

Carole North, 90TEN’s Co-Founder and CEO, said: “We have long admired Alison’s entrepreneurial flare and talent for breaking new ground in healthcare communications, and we are thrilled to welcome her to 90TEN. Our medical education team has had a record-breaking year, winning new clients in the US and Europe, and there couldn’t be a better time for Alison to bring her combination of scientific expertise and strategic nous to the mix.”